Free Trial
NASDAQ:GUTS

Fractyl Health (GUTS) Stock Price, News & Analysis

$4.19
+0.15 (+3.71%)
(As of 07/26/2024 ET)
Today's Range
$4.03
$4.27
50-Day Range
$3.89
$7.62
52-Week Range
$3.77
$14.50
Volume
79,048 shs
Average Volume
263,967 shs
Market Capitalization
$200.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00

Fractyl Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
425.1% Upside
$22.00 Price Target
Short Interest
Bearish
11.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.34mentions of Fractyl Health in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($2.03) to ($2.53) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.12 out of 5 stars

Medical Sector

807th out of 936 stocks

Surgical & Medical Instruments Industry

90th out of 101 stocks

GUTS stock logo

About Fractyl Health Stock (NASDAQ:GUTS)

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

GUTS Stock Price History

GUTS Stock News Headlines

Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
All About Gut Health Supplements, from An MD
Your Gut: A Guide to a Happier, Healthier Belly
Here’s What Alcohol Does to the Gut
Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
See More Headlines
Receive GUTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
7/26/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GUTS
Previous Symbol
NASDAQ:GUTS
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.00
High Stock Price Target
$26.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+435.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$120,000.00

Miscellaneous

Free Float
N/A
Market Cap
$196.87 million
Optionable
N/A
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Harith Rajagopalan M.D. (Age 47)
    Ph.D., Co-Founder, CEO & Director
    Comp: $863.77k
  • Mr. Jay D. Caplan BSEE (Age 62)
    MBA, Co-Founder, Chief Product Officer & President
    Comp: $555.19k
  • Dr. Timothy J. Kieffer Ph.D. (Age 57)
    Chief Scientific Officer
    Comp: $140.64k
  • Ms. Lisa A. Davidson MBA (Age 57)
    CFO & Treasurer
  • Ms. Sarah S. Toomey Esq. (Age 49)
    General Counsel & Corporate Secretary
    Comp: $479.36k
  • Dr. Helmut Giersiefen
    Head of Business Development
  • Mr. Adrian Kimber
    Chief Commercial Officer

GUTS Stock Analysis - Frequently Asked Questions

How have GUTS shares performed this year?

Fractyl Health's stock was trading at $12.85 on January 1st, 2024. Since then, GUTS shares have decreased by 67.4% and is now trading at $4.19.
View the best growth stocks for 2024 here
.

How were Fractyl Health's earnings last quarter?

Fractyl Health, Inc. (NASDAQ:GUTS) issued its quarterly earnings results on Monday, May, 13th. The company reported ($0.75) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.45. The business earned $0.03 million during the quarter.

When did Fractyl Health IPO?

Fractyl Health (GUTS) raised $110 million in an IPO on Friday, February 2nd 2024. The company issued 7,333,333 shares at $15.00 per share.

When does Fractyl Health's lock-up period expire?

Fractyl Health's lock-up period expires on Wednesday, July 31st. Fractyl Health had issued 7,333,333 shares in its initial public offering on February 2nd. The total size of the offering was $109,999,995 based on an initial share price of $15.00. After the end of Fractyl Health's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

How do I buy shares of Fractyl Health?

Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GUTS) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners